$296 M

PASG Mkt cap, 14-Jan-2022
Passage Bio Net income (Q1, 2021)-38.9 M
Passage Bio EBIT (Q1, 2021)-38.9 M
Passage Bio Cash, 31-Mar-2021249.5 M
Get notified regarding key financial metrics and revenue changes at Passage BioLearn more
Banner background

Passage Bio Income Statement

Annual

USDFY, 2018FY, 2019FY, 2020

R&D expense

12.5m30.2m81.8m

General and administrative expense

928.0k7.0m30.1m

Operating expense total

13.5m37.2m111.9m

EBIT

(13.5m)(37.2m)(112.9m)

Interest income

696.0k670.0k

Net Income

(12.8m)(45.6m)(112.2m)

Quarterly

USDQ1, 2020Q2, 2020Q1, 2021

R&D expense

13.1m19.9m25.0m

General and administrative expense

4.8m7.4m12.5m

Operating expense total

17.9m27.3m37.4m

EBIT

(17.9m)(27.3m)(38.9m)

Interest income

327.0k132.0k52.0k

Net Income

(17.6m)(27.2m)(38.9m)

Passage Bio Balance Sheet

Annual

USDFY, 2018FY, 2019FY, 2020

Cash

24.9m158.9m135.0m

Prepaid Expenses

8.5m6.9m1.4m

Current Assets

33.4m165.8m317.2m

PP&E

28.0k1.1m2.8m

Total Assets

33.5m178.6m328.0m

Accounts Payable

212.0k629.0k5.3m

Current Liabilities

307.0k3.7m21.2m

Total Liabilities

2.5m4.3m23.3m

Common Stock

2.0k2.0k4.0k

Preferred Stock

43.1m230.6m

Additional Paid-in Capital

855.0k2.4m475.6m

Retained Earnings

(13.0m)(58.7m)(170.9m)

Total Equity

(12.2m)(56.3m)304.7m

Financial Leverage

-2.7 x-3.2 x1.1 x

Quarterly

USDQ1, 2020Q2, 2020Q1, 2021

Cash

366.8m353.4m249.5m

Prepaid Expenses

2.9m2.2m3.4m

Current Assets

382.1m368.2m450.9m

PP&E

1.1m1.1m6.6m

Total Assets

392.4m378.1m465.2m

Accounts Payable

2.5m7.2m6.2m

Current Liabilities

5.2m14.1m19.5m

Total Liabilities

5.8m14.7m23.7m

Common Stock

4.0k4.0k5.0k

Additional Paid-in Capital

462.9m466.8m651.3m

Retained Earnings

(76.2m)(103.4m)(209.8m)

Total Equity

386.7m363.4m441.5m

Financial Leverage

1 x1 x1.1 x

Passage Bio Cash Flow

Annual

USDFY, 2018FY, 2019FY, 2020

Net Income

(12.8m)(45.6m)(112.2m)

Depreciation and Amortization

134.0k800.0k

Accounts Payable

(163.0k)2.0m4.6m

Cash From Operating Activities

(18.6m)(39.9m)(80.5m)

Purchases of PP&E

(28.0k)(1.2m)

Cash From Investing Activities

(2.5m)(1.7m)(172.1m)

Cash From Financing Activities

46.0m175.6m228.8m

Net Change in Cash

24.9m134.0m(23.9m)

Quarterly

USDQ1, 2020Q2, 2020Q1, 2021

Net Income

(17.6m)(44.8m)(38.9m)

Depreciation and Amortization

49.0k247.0k211.0k

Accounts Payable

331.0k6.5m592.0k

Cash From Operating Activities

(21.9m)(33.6m)(30.7m)

Cash From Investing Activities

(99.0k)(193.0k)(20.4m)

Cash From Financing Activities

229.9m228.3m165.6m

Net Change in Cash

208.0m194.5m114.5m

Passage Bio Ratios

USDFY, 2018

Financial Leverage

-2.7 x